A Novel Switching of Artificial Intelligence to Generate Simultaneously Multimodal Images to Assess Inflammation and Predict Outcomes in Ulcerative Colitis—(With Video)
Marietta Iacucci(University Hospitals Birmingham NHS Foundation Trust), Enrico Grisan(University of Padua), Brian Hayes(Cork University Hospital), Miguel Puga‐Tejada(University College Cork), Valery Naranjo(Universitat Politècnica de València), Andrea Buda(Hospital of Prato), Ilaria Ditonno(University College Cork), Ivan Capobianco(University College Cork), Irene Zammarchi(APC Microbiome Institute), Rocío del Amor(Universitat Politècnica de València), Giovanni Santacroce(Università Cattolica del Sacro Cuore), Pablo Meseguer(Artificial Intelligence Research Institute), Raf Bisschops(Universität Hamburg), Bisi Bode Kolawole(London South Bank University), Subrata Ghosh(University College Cork), Rory Crotty(Cork University Hospital), Ujwala Chaudhari(London South Bank University)
Cited by 9
Related Papers
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
|New England Journal of Medicine|2012|1.1k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k
European evidence-based Consensus on the management of ulcerative colitis: Current management
|Journal of Crohn s and Colitis|2008|558
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment
|Journal of Crohn s and Colitis|2021|540